We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$106B
AUM Growth
+$15.3B
Cap. Flow
+$9.94B
Cap. Flow %
9.42%
Top 10 Hldgs %
16.94%
Holding
4,486
New
287
Increased
1,717
Reduced
1,772
Closed
419

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$708M
2
USB icon
US Bancorp
USB
+$349M
3
JPM icon
JPMorgan Chase
JPM
+$255M
4
MON
Monsanto Co
MON
+$210M
5
MPLX icon
MPLX
MPLX
+$205M

Sector Composition

Rank Sector Weight
1 Financials 11.41%
2 Technology 10.7%
3 Healthcare 9.52%
4 Consumer Discretionary 7.09%
5 Industrials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
3776
Cardiff Oncology
CRDF
$63M
$67K ﹤0.01%
209
-124
-37% -$45.2K
ATHX
3777
DELISTED
Athersys, Inc. Common Stock
ATHX
$67K ﹤0.01%
1,257
-42
-3% -$2.17K
NEOS
3778
DELISTED
Neos Therapeutics, Inc
NEOS
$67K ﹤0.01%
10,307
+36
+0.4% +$285
MXWL
3779
DELISTED
Maxwell Technologies Inc
MXWL
$67K ﹤0.01%
13,012
-21,011
-62% -$109K
NYMX
3780
DELISTED
Nymox Pharmaceutical Corp
NYMX
$66K ﹤0.01%
20,342
+300
+1% +$981
SHOS
3781
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$66K ﹤0.01%
+13,357
New +$83.2K
ECYT
3782
DELISTED
Endocyte, Inc. Common Stock
ECYT
$66K ﹤0.01%
21,180
-5,128
-19% -$16K
SYRE icon
3783
Spyre Therapeutics
SYRE
$8.5B
$64K ﹤0.01%
+400
New +$55.6K
ESIO
3784
DELISTED
Electro Scientific Industries
ESIO
$64K ﹤0.01%
11,437
-6,703
-37% -$39.2K
GST
3785
DELISTED
Gastar Exploration Inc.
GST
$64K ﹤0.01%
76,267
-904,324
-92% -$846K
MOBL
3786
DELISTED
MobileIron, Inc.
MOBL
$64K ﹤0.01%
23,494
-23,814
-50% -$73.6K
SDRL
3787
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
$63K ﹤0.01%
+99
New +$71.1K
OSIR
3788
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$62K ﹤0.01%
12,587
-2,298
-15% -$11.8K
AST
3789
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$62K ﹤0.01%
14,692
-6,734
-31% -$21.8K
ASXC
3790
DELISTED
Asensus Surgical, Inc.
ASXC
$61K ﹤0.01%
2,797
-1,858
-40% -$34K
ANTH
3791
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$61K ﹤0.01%
2,428
-497
-17% -$12.5K
ADVM
3792
DELISTED
Adverum Biotechnologies
ADVM
$60K ﹤0.01%
1,465
-3,505
-71% -$133K
VHC icon
3793
VirnetX Holding Corp
VHC
$53.8M
$60K ﹤0.01%
975
-686
-41% -$43K
DRNA
3794
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$60K ﹤0.01%
10,245
-43,867
-81% -$154K
ARLZ
3795
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$60K ﹤0.01%
12,361
-106,752
-90% -$487K
CDXS icon
3796
Codexis
CDXS
$158M
$59K ﹤0.01%
13,239
-1,804
-12% -$7.58K
DXLG icon
3797
Destination XL Group
DXLG
$32.9M
$59K ﹤0.01%
13,748
-3,142
-19% -$15.3K
SDLP
3798
DELISTED
SEADRILL PARTNERS LLC
SDLP
$59K ﹤0.01%
1,676
+437
+35% +$18.5K
HIL
3799
DELISTED
Hill International, Inc. Common Stock
HIL
$57K ﹤0.01%
12,384
-13,168
-52% -$57.3K
PER
3800
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$57K ﹤0.01%
20,174

Similar funds

Credit Suisse's Q3 2016 Portfolio in Review

As of Q3 2016, Credit Suisse held 4,486 positions worth $106B, up 17% from $90.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $9.94B of net new capital in Q3 2016, opening 287 new positions and adding to 1,717 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,400,274 shares worth $149M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $350M trimmed.

  • Credit Suisse's largest Q3 2016 buy was iShares Core S&P Small-Cap ETF: 2,400,274 shares worth $149M.
  • Credit Suisse added most to VanEck Gold Miners ETF in Q3 2016, an estimated $708M increase.
  • Credit Suisse's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $350M.
  • Credit Suisse fully exited EMC CORPORATION in Q3 2016, selling an estimated $410M.
  • Credit Suisse's ten largest holdings make up 17% of its $106B portfolio in Q3 2016.
  • Credit Suisse opened 287 new positions and closed 419 in Q3 2016.
  • Credit Suisse's portfolio value rose 17% quarter-over-quarter to $106B.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.